BioSpace News Archive

Biotech Beach

Journal of Clinical Cancer Research Publication Demonstrates that DCISionRT® Provides Prognostic and Predictive Power for Assessing a Patient’s DCIS Risk

Prelude Corporation is a leader in molecular diagnostics and personalized medicine for early stage breast cancer

August 2, 2018
·
5 min read
Business

Teva Reports Second Quarter 2018 Financial Results

Revenues of $4.7 billion

August 2, 2018
·
39 min read
Bio NC

Aerie Pharmaceuticals to Present at the Canaccord Genuity Growth Conference

Richard Rubino, Chief Financial Officer, will present in a fireside chat discussion at the Canaccord Genuity Growth Conference on Thursday, August 9, 2018 at 1:30 p.m.

August 2, 2018
·
2 min read
Policy

EVIO Labs Massachusetts Announces ISO 17025 Accreditation

Leading cannabis testing company receives accreditation by A2LA

August 2, 2018
·
3 min read
Business

Lockwood CEO, Matthew Schecter, Recognized as one of PharmaVoice 100 Most Inspiring People

Matthew Schecter, Founder and President/CEO of The Lockwood Group (Lockwood) has been recognized by PharmaVoice in their 2018 annual ranking of the 100 Most Inspirational People.

August 2, 2018
·
3 min read
Business

Akcea Therapeutics and PTC Therapeutics Collaborate to Commercialize Two Rare Disease Drugs in Latin America

PTC in-licenses regional rights to TEGSEDI™ and WAYLIVRA™ from Akcea

August 2, 2018
·
10 min read
Biotech Beach

Biocept Awarded Patent in Canada for its Target Selector CTC Platform

Further expands global patent estate for capturing and detecting biological targets of interest including rare cells such as circulating tumor cells (CTCs)

August 2, 2018
·
3 min read
Drug Development

MiMedx Announces Publication Of Phase 2B Clinical Trial Efficacy Data For Micronized dHACM In The Treatment Of Plantar Fasciitis In Foot & Ankle International

Publication in Peer-Reviewed Journal Underscores Statistically Significant Difference Seen in Pain and Foot Function Compared to Control Group

August 2, 2018
·
5 min read
Drug Development

Karuna Completes $42 Million Series A Financing Round to Advance Selective Muscarinic Receptor Agonist Program into Phase 2 Study

Participants include ARCH Venture Partners, Wellcome Trust, PureTech Health, Steven Paul M.D., and other undisclosed investors

August 2, 2018
·
5 min read
Pharm Country

Applied DNA Sciences Reaches New Milestones in Therapeutic Contract Research and Contract Manufacturing of Linear DNA

Diagnostics Shipments, Vaccines Research, CAR T, and System Development bring in Requests for DNA

August 2, 2018
·
5 min read